Jeff Yass Susquehanna International Group
Jeff Yass is a co-founder of Susquehanna International Group (SIG), a major global trading and market-making firm. SIG is known for options expertise, quantitative trading, and a training culture grounded in probabilistic decision-making. Yass’s firm is influential across derivatives markets even though it is less of a traditional long-only stock-picking franchise.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Tesla
TSLA
|
+$2.17B |
| 2 |
Microsoft
MSFT
|
+$619M |
| 3 |
Apple
AAPL
|
+$377M |
| 4 |
Booking.com
BKNG
|
+$319M |
| 5 |
State Street Energy Select Sector SPDR ETF
XLE
|
+$270M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Amazon
AMZN
|
+$1.48B |
| 2 |
iShares Russell 2000 ETF
IWM
|
+$896M |
| 3 |
Invesco QQQ Trust
QQQ
|
+$599M |
| 4 |
Citigroup
C
|
+$467M |
| 5 |
Alphabet (Google) Class A
GOOGL
|
+$430M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 91.29% |
| 2 | Technology | 2.06% |
| 3 | Consumer Discretionary | 1.55% |
| 4 | Financials | 1.15% |
| 5 | Healthcare | 0.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GATO
11276
PUT
DELISTED
Gatos Silver, Inc.
GATO
| $53.6K | ﹤0.01% |
13,100
-40,000
| -75% | -$145K |
|
|
IDEX
11277
PUT
DELISTED
Ideanomics, Inc. Common Stock
IDEX
| $53.6K | ﹤0.01% |
2,678
-7,899
| -75% | -$229K |
|
|
MESO
11278
CALL
Mesoblast
MESO
$2.26B
| $53.5K | ﹤0.01% |
9,200
+100
| +1% | +$625 |
|
11279
Galectin Therapeutics
GALT
$405M
| $53.3K | ﹤0.01% |
47,208
+29,623
| +168% | +$39.5K |
|
11280
Direct Digital Holdings
DRCT
$1.81M
| $53.2K | ﹤0.01% |
+99
| New | +$57.2K |
|
11281
Evolv Technologies
EVLV
$949M
| $53.1K | ﹤0.01% |
20,503
-3,619
| -15% | -$10.7K |
|
11282
Data I/O
DAIO
$30.5M
| $52.9K | ﹤0.01% |
13,334
-112
| -0.8% | -$405 |
|
11283
PUT
AirSculpt Technologies
AIRS
$187M
| $52.9K | ﹤0.01% |
+14,300
| New | +$66.4K |
|
11284
PUT
Spruce Power Holding Corp
SPRU
$36M
| $52.8K | ﹤0.01% |
7,175
-4,700
| -40% | -$33.4K |
|
|
MNTX
11285
CALL
DELISTED
Manitex International, Inc.
MNTX
| $52.8K | ﹤0.01% |
+13,200
| New | +$61.1K |
|
11286
Sky Harbour Group
SKYH
$418M
| $52.6K | ﹤0.01% |
19,792
-900
| -4% | -$2.9K |
|
11287
CALL
iBio
IBIO
$67.6M
| $52.6K | ﹤0.01% |
5,980
+5,777
| +2,846% | +$195K |
|
|
HYRE
11288
CALL
DELISTED
HyreCar Inc. Common Stock
HYRE
| $52.5K | ﹤0.01% |
125,100
-6,600
| -5% | -$4.16K |
|
11289
PUT
Aurora
AUR
$11.7B
| $52.5K | ﹤0.01% |
+43,400
| New | +$74K |
|
|
INFI
11290
DELISTED
Infinity Pharmaceuticals, Inc.
INFI
| $52.5K | ﹤0.01% |
94,564
+64,543
| +215% | +$54.9K |
|
11291
PUT
CPS Technologies
CPSH
$73.7M
| $52.5K | ﹤0.01% |
19,500
-15,200
| -44% | -$46.1K |
|
11292
CALL
Amneal Pharmaceuticals
AMRX
$6.11B
| $52.3K | ﹤0.01% |
26,300
-99,300
| -79% | -$223K |
|
|
CMRX
11293
CALL
DELISTED
Chimerix, Inc.
CMRX
| $52.3K | ﹤0.01% |
28,100
-43,400
| -61% | -$84.9K |
|
11294
CALL
Energous
WATT
$61.4M
| $52K | ﹤0.01% |
103
+8
| +8% | +$4.82K |
|
11295
CALL
Olema Pharmaceuticals
OLMA
$899M
| $51.9K | ﹤0.01% |
21,200
-22,400
| -51% | -$65.3K |
|
|
BIOR
11296
CALL
DELISTED
Biora Therapeutics, Inc. Common Stock
BIOR
| $51.9K | ﹤0.01% |
1,597
-856
| -35% | -$62.4K |
|
11297
CALL
The Beachbody Company
BODI
$42.5M
| $51.9K | ﹤0.01% |
1,958
-964
| -33% | -$41.8K |
|
11298
PUT
Hycroft Mining Holding Corp
HYMC
$2.22B
| $51.8K | ﹤0.01% |
9,780
-3,990
| -29% | -$25.5K |
|
|
SUNW
11299
CALL
DELISTED
Sunworks, Inc.
SUNW
| $51.8K | ﹤0.01% |
32,800
-75,500
| -70% | -$169K |
|
11300
PUT
EyePoint Inc
EYPT
$386M
| $51.8K | ﹤0.01% |
14,800
-7,100
| -32% | -$31.3K |
|
Similar funds
Jeff Yass's Q4 2022 Portfolio in Review
As of Q4 2022, Jeff Yass held 14,748 positions worth $395B, up 2.2% from $387B the previous quarter. Its ten largest holdings account for 27% of the portfolio.
Jeff Yass's Q4 2022 filing shows 1,670 new, 4,598 increased, 5,764 reduced and 2,486 closed positions. Its largest new stake was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M. The largest sale was Amazon, an estimated $1.48B.
By sector, the portfolio is most concentrated in Miscellaneous at 91% of assets, down from 92% a quarter earlier, followed by Technology and Consumer Discretionary.
- Jeff Yass's largest Q4 2022 buy was Vanguard FTSE All-World ex-US ETF: 2,560,357 shares worth $128M.
- Jeff Yass added most to Tesla in Q4 2022, an estimated $2.17B increase.
- Jeff Yass's biggest Q4 2022 reduction was Amazon, cutting an estimated $1.48B.
- Jeff Yass fully exited Twitter, Inc. in Q4 2022, selling an estimated $76M.
- Jeff Yass's ten largest holdings make up 27% of its $395B portfolio in Q4 2022.
- Jeff Yass opened 1,670 new positions and closed 2,486 in Q4 2022.
- Jeff Yass's portfolio value rose 2.2% quarter-over-quarter to $395B.
Based on Susquehanna International Group's 13F filing for Q4 2022, filed 14 Feb 2023.